Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study offers 'real hope' for C.diff sufferers
Stomach pain
In the US alone, almost 500,000 C.diff infections occurred in 2011, resulting in 29,000 deaths.
Harmless spores of C.diff prevent repeated infection

Giving spores of non-toxic Clostridium difficile (C.diff) by mouth is effective in stopping bouts of C.diff infection, according to a study published in The Journal of American Medical Association.
 
C.diff infection is a type of bacterial infection that affects the digestive system. It most commonly affects those who have been treated with antibiotics.

Symptoms include severe diarrhoea, a high temperature and painful abdominal cramps.

Lead author Dale Gerding, professor of medicine at Loyola University Medical Centre (LUMC), Chicago, said: "Results of this study confirm findings of earlier studies that showed that if we can establish non-toxic C.diff as a resident of the gut of the patient, that we can protect the patient from infection by the toxic strains of C.diff.”

He adds that the results are worthy of further study to confirm that treatment with non-toxic C.diff spores can reduce recurrent C.diff infection and prevent a first episode of C.diff infection in those who are taking any antibiotics and are at high risk of infection.

Dale Gerding and an international team of infectious disease researchers ran trials on 173 adult patients.  Of those assigned non-toxic C.diff in liquid form, 11 per cent experienced a repeat infection within 42 days, compared with 30 per cent of those given a placebo - showing a significant reduction.

Hospital acquired infections, including C.diff, are an increasing problem throughout the world. In the US alone, almost 500,000 C.diff infections occurred in 2011, resulting in 29,000 deaths.

Stuart Johnson, infectious disease specialist at LUMC, said that the study offers 'real hope' for those debilitated by recurring bouts of the infection.

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.